Pelthos Therapeutics appointed Andrew J. Einhorn to its Board of Directors effective immediately.
Mr. Einhorn brings over four decades of finance, capital markets, and life sciences experience to Pelthos.
He will also serve on the Audit Committee and the Compensation Committee of the Pelthos Board.
Extensive Experience
Andrew Einhorn brings more than four decades of experience in investment banking and capital markets.
Financial Leadership
Mr. Einhorn served as CFO at multiple clinical and commercial-stage biotechnology companies.
Strategic Guidance
Currently acting as a consultant at Danforth Advisors, providing financial guidance to life science companies.
- Mr. Einhorn's appointment enhances Pelthos' financial expertise and industry connections.
- His role on the Board will support the company's growth as a commercially focused entity.
Andrew Einhorn's addition to the Pelthos Board signifies a strategic move to strengthen financial governance and growth prospects. His wealth of experience is expected to propel Pelthos toward a successful future.